Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis<sup>*</sup>

WANG Xin-ru; LUAN Jing-xiang; GUO Zhao-an

doi:10.1007/s11655-024-3805-6

Your Location：

Home >

Browse articles >

Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*

Review | Updated：2025-04-22

- Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*
- Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*
- 中国结合医学杂志（英文版） 2025年31卷第5期页码：474-480
- Affiliations：
  
  1.First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan (250014), China
  2.Department of Nephrology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan (250014), China
- Author bio：
  
  Prof. GUO Zhao-an, E-mail: gza63@163.com
- Funds：
  
  Shandong Natural Science Foundation Project(ZR2022LZY005)
- DOI：10.1007/s11655-024-3805-6
  中图分类号：
- 录用日期：2023-12-07，
  
  网络出版日期：2024-06-08，
  
  纸质出版日期：2025-05
- Accepted：
Scan QR Code
Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*[J]. 中国结合医学杂志（英文版）, 2025,31(5):474-480.

WANG Xin-ru, LUAN Jing-xiang, GUO Zhao-an. Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*[J]. Chinese journal of integrative medicine, 2025, 31(5): 474-480.
Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*[J]. 中国结合医学杂志（英文版）, 2025,31(5):474-480. DOI： 10.1007/s11655-024-3805-6.

WANG Xin-ru, LUAN Jing-xiang, GUO Zhao-an. Mechanism of Astragaloside Ⅳ in Treatment of Renal Tubulointerstitial Fibrosis^*[J]. Chinese journal of integrative medicine, 2025, 31(5): 474-480. DOI： 10.1007/s11655-024-3805-6.

摘要

Abstract

Tubulointerstitial fibrosis (TIF) is one of the key indicators in evaluating the renal function of patients. Mild TIF can cause a vicious cycle of renal tubular glomerular injury and aggravate renal disease. Therefore

studying the mechanisms underlying TIF is essential to identify therapeutic targets

thereby protecting the renal function of patients with timely intervention. Astragaloside Ⅳ (AS-Ⅳ) is a Chinese medicine component that has been shown to inhibit the occurrence and progression of TIF via multiple pathways. Previous studies have reported that AS-Ⅳ protected against TIF by inhibiting inflammation

autophagy

endoplasmic reticulum stress

macrophages

and transforming growth factor-β1

which laid the foundation for the development of a new preventive and therapeutic option for TIF.

关键词

Keywords

references

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Mechanism of Reactive Oxygen/Nitrogen Species in Liver Ischemia-Reperfusion Injury and Preventive Effect of Chinese Medicine^*

Pharmacological Mechanism of Chinese Medicine in Systemic Lupus Erythematosus: A Narrative Review

Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma

Targeting Therapeutic Windows for Rheumatoid Arthritis Prevention

Electroacupuncture Promotes Functional Recovery after Facial Nerve Injury in Rats by Regulating Autophagy via GDNF and PI3K/mTOR Signaling Pathway